Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1233355

Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19?


Ferenc, Thomas; Vilibić-Čavlek, Tatjana
Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19? // Acta clinica Croatica, 61 (2022), 1; 107-113 doi:10.20471/acc.2022.61.01.13 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1233355 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19?

Autori
Ferenc, Thomas ; Vilibić-Čavlek, Tatjana

Izvornik
Acta clinica Croatica (0353-9466) 61 (2022), 1; 107-113

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Common variable immunodeficiency ; COVID-19 ; SARS-CoV-2

Sažetak
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The usual presentation of the disease is a common cold-like illness but it can present with more severe and sometimes fatal manifestations. Immunocompromised patients such as those with common variable immunodeficiency (CVID) also are among the infected population. A limited number of reports have been published concerning CVID patients with COVID-19. The main reported symptoms were fever, cough, dyspnea and fatigue while the median duration of illness was 19 (interquartile range 14-26.5) days. Total recovery rate was 88.4%. It is still unknown whether primary immunodeficiency interacts as a predisposing or protective factor against the severe forms of COVID-19. Substitute immunoglobulin (IG) therapy is the only treatment option for CVID. Some reports suggest that early administration of intravenous IGs or convalescent plasma infusion may positively influence the outcome of COVID-19 in these patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Hrvatski zavod za javno zdravstvo,
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb

Profili:

Avatar Url Thomas Ferenc (autor)

Avatar Url Tatjana Vilibić-Čavlek (autor)

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Ferenc, Thomas; Vilibić-Čavlek, Tatjana
Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19? // Acta clinica Croatica, 61 (2022), 1; 107-113 doi:10.20471/acc.2022.61.01.13 (međunarodna recenzija, pregledni rad, znanstveni)
Ferenc, T. & Vilibić-Čavlek, T. (2022) Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19?. Acta clinica Croatica, 61 (1), 107-113 doi:10.20471/acc.2022.61.01.13.
@article{article, author = {Ferenc, Thomas and Vilibi\'{c}-\v{C}avlek, Tatjana}, year = {2022}, pages = {107-113}, DOI = {10.20471/acc.2022.61.01.13}, keywords = {Common variable immunodeficiency, COVID-19, SARS-CoV-2}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2022.61.01.13}, volume = {61}, number = {1}, issn = {0353-9466}, title = {Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19?}, keyword = {Common variable immunodeficiency, COVID-19, SARS-CoV-2} }
@article{article, author = {Ferenc, Thomas and Vilibi\'{c}-\v{C}avlek, Tatjana}, year = {2022}, pages = {107-113}, DOI = {10.20471/acc.2022.61.01.13}, keywords = {Common variable immunodeficiency, COVID-19, SARS-CoV-2}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2022.61.01.13}, volume = {61}, number = {1}, issn = {0353-9466}, title = {Common Variable Immunodeficiency: Predisposing or Protective Factor for Severe Complications of COVID-19?}, keyword = {Common variable immunodeficiency, COVID-19, SARS-CoV-2} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font